21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Method for Inhibiting the Activity of DPP-IV and Lowering Blood Glucose Level
#8402METHODS TO TREAT NEURODEGENERATIVE CONDITIONS OR DISEASES BY TARGETING COMPONENTS OF A PTEN SIGNALING PATHWAY
#8403Methods and compositions for oxygenation of skin to treat skin disorders
#8404TREATMENT OF LUNG CANCER
#8405STABLE SOLID ORAL DOSAGE CO-FORMULATIONS
#8406DERMAL FILLERS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF
#8407TELMISARTAN AND HYDROCHLOROTHIAZIDE COMBINATION THERAPY
#8408Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
#8409COMPOSITION FOR WOUND HEALING
#8410MUSHROOM COMPOSITIONS AND METHODS FOR MAKING AND USING
#8411Treatment of Disease with Proteasone Inhibitors
#8412Methods and Compositions for Treating Conditions of the Eye
#8413Chronic lymphocytic leukemia prognosis and treatment
#8414COMPOSITIONS AND METHODS FOR TREATING, REDUCING, AMELIORATING, ALLEVIATING, OR INHIBITING PROGRESSION OF, PATHOGENIC OCULAR NEOVASCULARIZATION
#8415COMBINATION OF HGF INHIBITOR AND PTEN AGONIST TO TREAT CANCER
#8416Veterinary topical agent
#8417Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
#8418LACTOSE COMPOSITIONS WITH DECREASED LACTOSE CONTENT
#8419Repair and/or reconstitution of invertebral discs
#8420ACTIVE VARIANTS OF THE IL-18 BINDING PROTEIN AND MEDICAL USES THEREOF
#8421Compositions containing interleukin-1 and peptides
#8422Modulators of HSP70/DnaK Function and Methods of Use Thereof
#8423Aegyptin and uses thereof
#8424Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#8425Colon lavage system
#8426Antibody therapy
#8427Method for Treating Liver Disorders with Receptor Associated Protein (RAP) Peptide-Fucosidase Inhibitor Conjugates
#8428METHOD OF MAKING DENSE, CONFORMAL, ULTRA-THIN CAP LAYERS FOR NANOPOROUS LOW-K ILD BY PLASMA ASSISTED ATOMIC LAYER DEPOSITION
#8429NOVEL SINGLE UNIT CARBAPENEM AMINOGLYCOSIDE FORMULATIONS
#8430Compositions and methods for therapeutic delivery with microorganisms
#8431Methods and devices for denervation
#8432Methods for the treatment of radiation or chemotherapy-induced tissue damage
#8433USE OF (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDES FOR THE MANUFACTURE OF MEDICAMENTS ACTIVE AS SODIUM AND/OR CALCIUM CHANNEL SELECTIVE MODULATORS
#8434USE OF SPONGOSINE FOR THE TREATMENT OF PAIN
#8435Therapeutic agent for hepatitis C
#8436Treatment of neurodegenerative conditions
#8437PARENTERAL TREATMENT WITH STATINS
#8438Alpha-lipoic acid concentrate
#8439Pharmaceutical formulation
#8440Derivatives of pyridoxine for inhibiting HIV integrase
#8441METHOD AND COMPOSITION FOR THERMALLY STABILIZING VITAMIN C WITHIN NANO LAYERS OF MONTMORILLONITE CLAY
#8442Inhibitors of bruton'S tyrosine kinase
#8443ELTOPRAZINE FOR SUPPRESSION OF L-DOPA INDUCED DYSKINESIAS
#8444Therapeutic agent for migraine
#8445Method of treating atrial fibrillation
#8446ANTIFUNGAL COMBINATION THERAPY
#8447Smoothened antagonism for the treatment of hedgehog pathway-related disorders
#8448Use of Fulvestrant in the Treatment of Resistant Breast Cancer
#8449Concurrent therapy regime/regimen for the treatment of acne related diseases
#8450Methods and Compositions for Treating Alzheimer's Disease
#8451Compositions comprising sugar-cysteine products
#8452Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells
#8453Treatment of mood and anxiety disorders
#8454Methods and compositions for the treatment of obesity
#8455Polyheterocyclic compounds highly potent as HCV inhibitors
#8456Compositions and methods for therapeutic delivery with microorganisms
#8457Compositions and methods for therapeutic delivery with microorganisms
#8458Compositions and methods for therapeutic delivery with microorganisms
#8459Compositions and methods for therapeutic delivery with microorganisms
#8460ENHANCEMENT OF MAGENESIUM UPTAKE IN MAMMALS
#8461Compositions containing nucleosides and manganese and their uses
#8462Methods of screening for and treating autism spectrum disorders and compositions for same
#8463Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function
#8464Medical composition for inhibiting the growth of cancer stem cell
#8465Herbal composition for improving skin quality and method for making the same
#8466Composition and method for topical treatment of skin lesions
#8467Cardioplegic preparation
#8468Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity
#8469Compositions and methods for treating osteoarthritis
#8470Suspension formulations
#8471LIPOSOME TREATMENT OF VIRAL INFECTIONS
#8472In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation
#8473LOW-CONCENTRATION CAPSAICIN PATCH AND METHODS FOR TREATING NEUROPATHIC PAIN
#8474Implants for administering substances and methods of producing implants
#8475Osteoimplant and methods for making
#8476METHODS OF IMMUNE OR HEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER, CANCER SYMPTOMS, OR THE SYMPTOMS OF CANCER TREATMENTS
#8477IMMUNE SYSTEM STIMULATING NUTRITION
#8478Methods for renal denervation
#8479METHOD OF TREATING T CELL MEDIATED DISORDERS
#8480Administration of an Inhibitor of HDAC, an Inhibitor of HER-2, and a Selective Estrogen Receptor Modulator
#8481Formulations and treatments for well-being
#8482Combination Therapies Against Cancer
#8483Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#8484Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#8485Compositions and methods for therapeutic delivery with microorganisms
#8486IL28 AND IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
#8487ORGANIC COMPOUNDS AND THEIR USES
#8488USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS
#8489Topical cosmetic skin lightening compositions and methods of use thereof
#8490Methods and compositions for the treatment of symptoms of neurological and mental health disorders
#8491Sexual Hygienic Composition
#84921-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS
#8493Topical formulations for treatment of neuropathy
#8494SALTS OF TRAMADOL AND IBUPROFEN AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN
#8495Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
#8496Inhibition of interaction of PSD93 and PSDS95 with nNOS and NMDA receptors
#8497Set of Antiangiogenic Molecules and Use Thereof
#8498Methods of treating chemoresistance and relapse in cancer cells
#8499HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF
#8500Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
#8501Methods for treating pain
#8502PALONOSETRON FOR THE TREATMENT OF CHEMOTHERAPY INDUCED EMESES
#8503Methods of treating traveler's diarrhea and hepatic encephalopathy
#8504CLINICAL BENEFITS OF EICOSAPENTAENOIC ACID IN HUMANS
#8505Pharmaceutical combination
#8506Medical intervention in haematological cancers
#8507Topical skin care composition
#8508USE OF CYCLOLIGNANS FOR THE TREATMENT OF A HYPERACTIVE IMMUNE SYSTEM
#8509AVERMECTIN/HYDROCORTISONE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN. E.G., ROSACEA
#8510Stabilized formulation of triamcinolone acetonide
#8511Methods for treating glioblastoma
#8512AMYLOID BETA-PEPTIDES AND METHODS OF USE THEREOF
#8513NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII
#8514Modified vasoactive intestinal peptides
#8515Use of peptides for promoting wound healing
#8516Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
#8517Compositions for Enhancing the Production of PPAR and/or PPAR-Associated Factors
#8518Spiro-imidazolone derivatives as glucagon receptor antagonists
#8519BLOAT THERAPEUTIC AGENT FOR A RUMINANT
#8520Method of preparing a muscadine pomace extract
#8521Herbal extract as sensitivity enhancer toward insulin and antidiabetes
#8522Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or infections
#8523IMPLANTABLE NEUROENDOPROSTHETIC SYSTEM, A METHOD OF PRODUCTION THEREOF AND A METHOD OF RECONSTRUCTIVE NEUROSURGICAL OPERATION
#8524Galenical Formulation Comprising Aliskiren and Process for its Preparation by Melt Extrusion Granulation
#8525METHODS OF DELIVERY OF AGENTS TO LEUKOCYTES AND ENDOTHELIAL CELLS
#8526Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
#8527METHOD AND PRODUCT
#8528USE OF OPIOID ANTAGONISTS FOR TREATING URINARY RETENTION
#8529Methods and compositions using peroxiredoxin 1 (PRX1) as an adjuvant
#8530Individual 5-fluorouracile dose optimization in folfiri treatment
#8531COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
#8532METHODS OF TREATING AND PREVENTING NEUROLOGICAL DISORDERS USING DOCOSAHEXAENOIC ACID
#8533IAP BIR DOMAIN BINDING COMPOUNDS
#8534Methods comprising serratia peptidase for inhibition of osteomyelitis
#8535Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#8536Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis
#8537Nutritional Formulas Containing Synbiotics
#8538Hepatitis C inhibitor compounds
#8539COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha
#8540Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections
#8541WOUND HEALING
#8542Use of truncated cysteine IL28 and IL29 Mutants to treat cancers and autoimmune disorders
#8543Vitamin preparation
#8544Screening assay employing Dex and GDF8
#8545IMAGING AND THERAPY OF VIRUS-ASSOCIATED TUMORS
#8546Compliant composites for application of drug-eluting coatings to tissue surfaces
#8547High citrate dialysate and uses thereof
#8548Antiviral nucleosides
#8549Image quality in the eye
#8550Methods of providing weight loss therapy in patients with major depression
#8551DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE
#8552Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
#8553Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
#8554Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
#8555Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
#8556Compositions and methods for treatment of neurodegenerative disease
#8557PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM
#8558Composition of dialysis liquid comprising crystallisation inhibitor substances
#8559USE OF ANTI-CONNEXIN AGENTS FOR MODULATING THE THERAPEUTIC EFFECT OF PSYCHOTROPIC DRUGS
#8560ANTITUMOR AGENT CONTAINING 4 - [[3,5 - BIS (TRIMETHYLSILYL) BENZOYL] AMINO] BENZOIC ACID
#8561Micronutrient formulations for radiation applications
#8562Combination, kit and method of reducing intraocular pressure
#8563Methods and compositions for treating bleeding disorders
#8564TISSUE REGENERATION METHOD
#8565Method of regulating glucose metabolism, and reagents related thereto
#8566ELECTRON-IRRADIATED PHYSIOLOGICAL ISOTONIC SOLUTION AND ELECTRON IRRADIATION APPARATUS FOR PREPARING ELECTRON-IRRADIATED PHYSIOLOGICAL ISOTONIC SOLUTION AND ORGAN PRESERVATION CONTAINER
#8567METHOD FOR TREATMENT OF NEURAL INJURIES
#8568PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES
#8569Pharmaceutical material for psoriasis treatment
#8570METHOD OF TREATING OR PREVENTING DISEASE IN BEES
#8571Methods to extend vision to infrared wavelengths
#8572Composition containing ultra-micronized palmitoyl-ethanolamide
#8573Method for treating neurodegenerative disorders with oral dosage formulation containing both immediate-release and sustained-release drugs
#8574COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS
#8575COMPOSITION CONTAINING AT LEAST ONE NUTRIVITE, AT LEAST ONE DISINFECTING OR DECONTAMINATING, AND/OR AT LEAST ONE PROTEASE-INHIBITING ACTIVE COMPOUND AND/OR ACTIVE COMPOUND COMPLEX
#8576Citrate-based dialysate chemical formulations
#8577URICASE COMPOSITIONS AND METHODS OF USE
#8578Novel vascular endothelial growth factor expression inhibitors
#8579Nutritional supplement to improve supplementary target protein fraction (TPF) delivery, intracellular absorption and utilization
#8580NOVEL STRA6 POLYPEPTIDES
#8581Efficient well being assessment and improved treatment protocol
#8582Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (IRO) antagonists of TLR7 and TLR9
#8583METHOD OF TREATING HEARING LOSS USING XIAP
#8584PROTEIN C RS2069915 AS A RESPONSE PREDICTOR TO SURVIVAL AND ADMINISTRATION OF ACTIVATED PROTEIN C OR PROTEIN C-LIKE COMPOUND
#8585METHOD FOR REDUCING OR ELIMINATING PAIN ASSOCIATED WITH A POST-OPERATIVE WOUND
#8586METHODS AND COMPOSITIONS FOR TREATING URINARY TRACT INFECTIONS USING AGENTS THAT MIMIC OR ELEVATE CYCLIC AMP
#8587SUBSTITUTED AMINE DERIVATIVE AND MEDICINAL COMPOSITION COMPRISING SAME AS THE ACTIVE INGREDIENT
#8588Pharmacological vitreolysis
#8589COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#8590Compositions and methods for inhibiting entry of a hepatic virus
#8591Complement antagonists and uses thereof
#8592Synergistic Combinations of a Macrocyclic Inhibitor of HCV and a Nucleoside
#8593HUMAN G-CSF ANALOGS AND METHODS OF MAKING AND USING THEREOF
#8594Topical scar treatment composition
#8595FASUDIL IN COMBINATION THERAPIES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#8596(6S)-5-METHYLTETRAHYDROFOLIC ACID FOR THERAPY OF TISSUE INJURY
#8597Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract
#8598Anti-FcRH5 antibodies and immunoconjugates and methods of use
#8599Drug releasing coatings for medical devices
#8600Substrates for nitric oxide releasing devices
#8601Combinations of SAP depleting agents and anti-SAP antibodies
#8602MEDICINAL PRODUCT AND TREATMENT
#8603Enhancement of urogenital function
#8604PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
#8605COMPOSITION
#8606BALANCED MYRISTATE- AND LAURATE-CONTAINING EDIBLE OIL
#8607DIACYLGLYCEROL RICH FATS, OILS AND FUNCTIONAL FOODS
#8608PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF BONE LOSS
#8609Formoterol/steroid bronchodilating compositions and methods of use thereof
#8610SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#8611Protein kinase targeted therapeutics
#8612Substituted naphthalenyl-pyrimidine compounds
#8613Synergistic Combinations of Aztreonam with the Carbapenems Meropenem and Ertapenem
#8614METHOD FOR TREATING THE HYPERPIGMENTATION OF PATHOLOGICAL SCARS
#8615METHODS OF USE RELATED TO XEROSTOMIA
#8616ARTEMISININ AND DERIVATIVES THEREOF AS ANTIVIRALS
#8617Boron-containing small molecules
#8618Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
#8619MIXTURE OF HYALURONIC ACID FOR TREATING AND PREVENTING PEPTIC ULCER AND DUODENAL ULCER
#8620MIXTURE OF HYALURONIC ACID FOR TREATING AND PREVENTING INFLAMMATORY BOWEL DISEASE
#8621TAXANE COMPOUNDS FOR TREATING EYE DISEASE
#8622Compositions containing piperacillin and tazobactam useful for injection
#8623PHARMACEUTICAL COMPOSITION FOR USE IN TREATING SEXUALLY TRANSMITTED INFECTIONS
#8624Controlled release composition and method of producing the same
#8625COMBINED THERAPY AGAINST TUMORS COMPRISING SUBSTITUTED ACRYLOYL DISTAMYCIN DERIVATIVES AND RADIOTHERAPY
#8626Modulation of the Vps10p-domain for the treatment of cardiovascular disease
#8627COMPOSITION FOR BURN TREATMENT
#8628PREPARATION FOR THE TREATMENT OF THE ERECTILE DISORDER
#8629Xanthine oxidase inhibitor and uric acid production inhibitor
#8630Composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid
#8631TRAIL VARIANTS FOR TREATING CANCER
#8632Use of cilastatin to reduce nephrotatoxicity of various compounds
#8633REDUCING DRUG DEPENDENCE OR ADDICTION
#8634COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA
#8635MALIGNANT TUMOR HEAT THERAPY KIT COMPRISING ANTI-REGULATORY T CELL ANTIBODY AND MAGNETIC FINE PARTICLES AND HEAT THERAPY METHOD THEREOF
#8636Concurrent delivery of multiple therapeutic agents via hydrogels for biomedical applications
#8637DIRECTLY PRESSED ALISKIREN TABLETS
#8638Treatment of fructose malabsorption
#8639GASTRIC THERAPIES AND COMPOSITIONS THEREFOR
#8640METHOD FOR REDUCING LIPID ABSORPTION BY AN ANIMAL
#8641Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
#8642COMPOSITION FOR MUCOSAL ADMINISTRATION CONTAINING AGENT FOR ENHANCING MUCOSAL ABSORPTION OF PEPTIDE DRUG, AND ADMINISTRATION METHOD THEREOF
#8643Pyridine alkaloids, preparation process thereof, and the uses of the pyridine alkaloids
#8644Methods for Treating Cancers Comprising K-ras Mutations
#8645ANTI-EPCAM ANTIBODIES THAT INDUCE APOPTOSIS OF CANCER CELLS AND METHODS USING SAME
#8646METHODS OF TREATING METASTATIC BREAST CANCER WITH TRASTUZUMAB-MCC-DM1
#8647COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA
#8648COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE
#8649COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE
#8650Isolated organ perfusion combination therapy of cancer
#8651IGF-II/IGF-IIE BINDING PROTEINS
#8652Novel Herbal Composition for Treatment of Psoriasis and Other Skin Disorders
#8653METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY
#8654Enhanced Submucosal Tissue Graft Constructs
#8655USE OF PEGYLATED TYPE III INTERFERONS FOR THE TREATMENT OF HEPATITIS C
#8656TELAPREVIR DOSING REGIMEN
#8657COMPOSITIONS COMPRISING AVERMECTIN/AZELAIC ACID COMPOUNDS USEFUL FOR TREATING, E.G., ROSACEA
#8658COSMETIC AND/OR DERMATOLOGICAL COMPOSITION
#8659Immunotherapy of B-cell malignancies using anti-CD22 antibodies
#8660Swallowable drug delivery device and methods of drug delivery
#8661Drug releasing coatings for medical devices
#8662Drug releasing coatings for medical devices
#8663Ascorbate, vitamin K3 and hydroxytolans in the treatment of cancer
#8664COMPOSITION AND METHOD
#8665PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF BONE LOSS
#8666Antitumor agent
#8667Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
#8668INHIBITORS OF AKT ACTIVITY
#8669Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria
#8670Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
#8671Compositions and methods for eye whitening
#8672CONTROL OF INTRAOCULAR PRESSURE USING ALK5 MODULATION AGENTS
#8673Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
#8674Anti-Inflammatory Analgesic External Preparation
#8675CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS
#8676FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS
#8677Treatment of congestion using steroids and adrenergics
#8678Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases
#8679MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS
#8680Concentrated therapeutic phospholipid compositions
#8681Methods for heat shock protein dependent cancer treatment
#8682Pharmaceutical Composition for the Eradication of Helicobacter Pylori and Preparation Method Thereof
#8683CANCER TREATMENT METHOD
#8684Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#8685Drug releasing coatings for medical devices
#8686USE OF STRAINS OF LACTOBACILLUS AND BY-PRODUCTS THEREOF FOR INHIBITING FORMATION OF BLOOD VESSELS
#8687ALCOHOL METABOLISM ENHANCER AND ALCOHOLIC BEVERAGE
#8688Compositions and methods useful for treatment of respiratory illness
#8689Composition For Relieving Premenstrual Syndrome
#8690COMBINATION OF EXTRACTS OF VARIOUS PLANTS FOR IMPROVING THE SYMPTOMS OF DEMENTIA DISORDERS
#8691COMBINATION COMPRISING AN IRON CHELATOR AND AN ANTI-NEOPLASTIC AGENT AND USE THEREOF
#8692Recombinant alpha-fetoprotein and compositions thereof
#8693PHARMACEUTICAL COMBINATIONS
#8694Dermatological compositions containing an association of peroxide lipids and zinc, and uses thereof in particular in the treatment of labial and/or genital herpes
#8695Preparation of an enteric release system
#8696COMPOSITION COMPRISING LIPOSOME-ENTRAPPED DOXORUBICIN AND METHODS OF ADMINISTRATION
#8697Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support
#8698Methods For Treating Parkinson's Disease
#8699Antiseptic compositions and uses thereof
#8700Methods and materials for stimulating proliferation of stem cells